Dietary Supplement
Femarelle
Femarelle is a dietary supplement with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
completed133%
unknown133%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
A Twelve Week Study to Investigate the Efficacy of Femarelle®, for the Treatment of Post Menopausal Vaginal Atrophy
NCT01502527
withdrawnphase_4
Natural Soybean-derived Femarelle ®for Patients With Non Alcoholic Fatty Liver Disease
NCT01269320
unknownnot_applicable
A Double-Blind Study to Evaluate the Effect of Femarelle® on Menopausal on Vasomotor Symptoms
NCT01063725
Clinical Trials (3)
Showing 3 of 3 trials
NCT01502527Not Applicable
A Twelve Week Study to Investigate the Efficacy of Femarelle®, for the Treatment of Post Menopausal Vaginal Atrophy
NCT01269320Phase 4
Natural Soybean-derived Femarelle ®for Patients With Non Alcoholic Fatty Liver Disease
NCT01063725Not Applicable
A Double-Blind Study to Evaluate the Effect of Femarelle® on Menopausal on Vasomotor Symptoms
All 3 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 3